Mei Zhu Selected Research

Mei Zhu Research Topics

Disease

13	Neoplasms (Cancer) 04/2022 - 08/2011
7	Infections 01/2021 - 01/2018
5	Hypothyroidism 01/2022 - 02/2017
5	Hypertension (High Blood Pressure) 01/2021 - 01/2014
5	Inflammation (Inflammations) 12/2017 - 07/2009
4	Obstructive Sleep Apnea 01/2022 - 01/2019
4	Hyperthyroidism 01/2022 - 01/2015
4	Body Weight (Weight, Body) 01/2021 - 02/2015
4	Pain (Aches) 01/2021 - 04/2003
4	Brain Injuries (Brain Injury) 06/2011 - 05/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2019
3	Hypertriglyceridemia 01/2022 - 12/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 07/2006
3	Hypercholesterolemia 01/2022 - 12/2015
3	Goiter 12/2021 - 12/2018
3	Thyroid Nodule (Nodule, Thyroid) 11/2021 - 12/2018
3	Graves Disease (Basedow Disease) 01/2021 - 06/2015
3	Hyperuricemia 12/2020 - 04/2020
3	Insulin Resistance 12/2020 - 02/2015
3	Type 2 Diabetes Mellitus (MODY) 12/2020 - 11/2019
3	Human Influenza (Influenza) 11/2020 - 01/2020
3	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 08/2020 - 02/2017
3	Obesity 08/2020 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2020 - 11/2016
3	Osteoarthritis 10/2019 - 01/2009
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 11/2016
3	Ovarian Neoplasms (Ovarian Cancer) 07/2016 - 02/2014
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2011 - 05/2010
3	Chronic Hepatitis B 05/2009 - 07/2005
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2022 - 01/2021
2	Hemorrhage 01/2022 - 06/2014
2	Thrombosis (Thrombus) 01/2022 - 06/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 01/2013
2	Thyroiditis 01/2021 - 06/2015
2	Heroin Dependence (Heroin Abuse) 01/2021 - 01/2018
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 07/2020 - 07/2017
2	Abdominal Obesity 01/2020 - 02/2015
2	Carcinoma (Carcinomatosis) 10/2019 - 04/2019
2	Osteoporosis 10/2019 - 01/2019
2	Heart Failure 11/2018 - 06/2013
2	Hypoxia (Hypoxemia) 03/2018 - 07/2012
2	Cushing Syndrome 01/2018 - 02/2014
2	Fibrosis (Cirrhosis) 01/2018 - 01/2013
2	Demyelinating Diseases (Demyelinating Disease) 12/2017 - 12/2017
2	Carcinogenesis 01/2017 - 11/2014
2	Hyperlipidemias (Hyperlipidemia) 11/2016 - 12/2015
2	Neoplasm Metastasis (Metastasis) 11/2014 - 02/2014
1	Aortic Coarctation 09/2022
1	Substance-Related Disorders (Drug Abuse) 05/2022
1	Lung Diseases (Lung Disease) 04/2022

Drug/Important Bio-Agent (IBA)

9	IodineIBA 12/2021 - 06/2015
7	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2021 - 12/2015
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 06/2011
4	LipidsIBA 01/2022 - 11/2016
4	AutoantibodiesIBA 01/2021 - 02/2017
4	EnzymesIBA 07/2017 - 02/2006
3	Peptides (Polypeptides)IBA 04/2022 - 01/2021
3	CytokinesIBA 01/2021 - 07/2020
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2014
3	LDL CholesterolIBA 08/2020 - 12/2015
3	Iodide Peroxidase (Deiodinase)IBA 08/2020 - 01/2020
3	Thyroglobulin FDA Link 08/2020 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 01/2013
3	oxidized low density lipoproteinIBA 08/2020 - 01/2019
3	Lamivudine (Epivir)FDA Link 05/2009 - 07/2005
2	Therapeutic UsesIBA 05/2022 - 12/2017
2	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 11/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2018
2	CholesterolIBA 08/2020 - 01/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2020 - 02/2015
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2006
2	AntibodiesIBA 01/2020 - 01/2020
2	Neuroprotective AgentsIBA 01/2019 - 09/2010
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2018 - 11/2016
2	CateninsIBA 01/2017 - 01/2014
2	Insulin (Novolin)FDA Link 02/2015 - 06/2013
2	Evans Blue (Blue, Evans)FDA Link 01/2014 - 05/2010
2	OligosaccharidesIBA 01/2014 - 02/2006
2	Capsules (Microcapsules)IBA 01/2014 - 07/2012
2	CCAAT-Enhancer-Binding ProteinsIBA 08/2012 - 01/2012
2	ginsenoside Rb1IBA 01/2011 - 05/2010
2	EscinIBA 09/2010 - 07/2009
2	beta CateninIBA 03/2010 - 01/2009
2	Hepatitis B e AntigensIBA 05/2009 - 07/2005
1	Coenzyme A (CoA)IBA 09/2022
1	Inosine FDA Link 05/2022
1	Metformin (Glucophage)FDA LinkGeneric 05/2022
1	Tumor Biomarkers (Tumor Markers)IBA 04/2022

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2003
3	Drug Therapy (Chemotherapy) 01/2020 - 06/2013
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2016 - 05/2010
2	Percutaneous Coronary Intervention 01/2020 - 06/2019
2	Microbubbles 01/2014 - 02/2012